title: [Tridazol efficacy and tolerance in the treatment of lambliasis].
abstract: The data on the clinical trials of the antiprotozoan agent tridazole-500 are presented. Drug parasitocidal activity and tolerance have been determined. The treatment was performed in 31 patients with lambliasis. A satisfactory drug tolerance and a 77.4% efficacy have been established.
authors.forename: N Kh
authors.initials: NKh
authors.lastname: Ziganshina
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Fuzaĭlov
mesh_terms: D000328:Adult; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005873:Giardiasis / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets; D014011:Tinidazole / Q000627:therapeutic use*
chemical_list: D013607:Tablets; D014011:Tinidazole
vernacular_title: Effektivnost' i perenosimost' tridazola pri lechenii liamblioza.